MX2007007604A - Antagonistas del receptor de pirazolo[1,5-a]pirimidina adenosina a2a. - Google Patents

Antagonistas del receptor de pirazolo[1,5-a]pirimidina adenosina a2a.

Info

Publication number
MX2007007604A
MX2007007604A MX2007007604A MX2007007604A MX2007007604A MX 2007007604 A MX2007007604 A MX 2007007604A MX 2007007604 A MX2007007604 A MX 2007007604A MX 2007007604 A MX2007007604 A MX 2007007604A MX 2007007604 A MX2007007604 A MX 2007007604A
Authority
MX
Mexico
Prior art keywords
optionally substituted
alkyl
cycloalkyl
hydrogen
optionally
Prior art date
Application number
MX2007007604A
Other languages
English (en)
Inventor
Samuel Chackalamannil
Bernard R Neustadt
Martin C Clasby
Xiaobang Gao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX2007007604A publication Critical patent/MX2007007604A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen los compuestos que tienen la formula estructural I (ver formula I) en donde A es alquileno, o arileno, cicloalquileno o heteroarildiilo opcionalmente sustituido; X es -C(O)- o -S(O)2-; R1 es alquilo o cicloalquilo; R2 es hidrogeno, halo o -CN; R3 es hidrogeno o alquilo; R4 es hidrogeno, alquilo, alcoxi, hidroxialquilo, aminoalquilo-, cicloalquilo, heterocicloalquilo, heterocicloalquilo sustituido por alquilo, arilalquilo opcionalmente sustituido o heteroarilalquilo opcionalmente sustituido; o R3 y R4, a partir de un anillo de 5-7 miembros opcionalmente sustituido, dicho anillo comprende opcionalmente un miembro de anillo heteroatomo adicional; R7 es alquilo, fenilo opcionalmente sustituido, heteroarilo opcionalmente sustituido, cicloalquilo, halo, morfolinilo, piperazinilo opcionalmente sustituido, o azacicloalquilo opcionalmente sustituido; tambien se describe el uso de los compuestos en el tratamiento de la enfermedad de Parkinson, solos o en combinaciones con otros agentes para el tratamiento de la enfermedad de Parkinson, composiciones farmaceuticas que los comprenden y equipos que comprenden los componentes de las combinaciones.
MX2007007604A 2004-12-21 2005-12-19 Antagonistas del receptor de pirazolo[1,5-a]pirimidina adenosina a2a. MX2007007604A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63802804P 2004-12-21 2004-12-21
PCT/US2005/045658 WO2006068954A2 (en) 2004-12-21 2005-12-19 PYRAZOLO[1,5-A]PYRIMIDINE ADENOSINE A2a RECEPTOR ANTAGONISTS

Publications (1)

Publication Number Publication Date
MX2007007604A true MX2007007604A (es) 2007-08-02

Family

ID=36602229

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007604A MX2007007604A (es) 2004-12-21 2005-12-19 Antagonistas del receptor de pirazolo[1,5-a]pirimidina adenosina a2a.

Country Status (11)

Country Link
US (1) US7741318B2 (es)
EP (1) EP1836205B1 (es)
JP (1) JP2008524330A (es)
CN (1) CN101119998A (es)
AT (1) ATE433454T1 (es)
CA (1) CA2591125A1 (es)
DE (1) DE602005014891D1 (es)
ES (1) ES2327145T3 (es)
HK (1) HK1108882A1 (es)
MX (1) MX2007007604A (es)
WO (1) WO2006068954A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196078B2 (en) * 2002-09-04 2007-03-27 Schering Corpoartion Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
US20060128694A1 (en) * 2002-12-19 2006-06-15 Michael Grzelak Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
ES2685837T3 (es) * 2006-08-28 2018-10-11 Merck Sharp & Dohme Corp. Proceso y productos intermedios para la síntesis de derivados de (3-alquil-5-piperidin-1-il-3,3a-dihidropirazolo[1,5-a]pirimidin-7-il)-amino
CA2720944C (en) * 2008-04-07 2012-12-18 Irm Llc Compounds and compositions as kinase inhibitors
US20100093721A1 (en) * 2008-10-13 2010-04-15 Barbay J Kent PHENYL AND HETEROARYL SUBSTITUTED THIENO[2,3-d]PYRIMIDINES AND THEIR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
EP2210891A1 (en) * 2009-01-26 2010-07-28 Domain Therapeutics New adenosine receptor ligands and uses thereof
WO2010140339A1 (ja) * 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
CN101906105B (zh) * 2009-06-08 2013-01-16 河北医科大学 吡唑并[1，5-a]嘧啶酮衍生物及其药物组合物以及其用途
WO2011061754A1 (en) * 2009-11-18 2011-05-26 Council Of Scientific & Industrial Research A novel 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2h-thiazolo [4,5-di pyrimidin-6-yl - and process for preparation thereof
ES2540867T3 (es) * 2010-02-26 2015-07-14 Mitsubishi Tanabe Pharma Corporation Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
MA34299B1 (fr) * 2010-06-04 2013-06-01 Hoffmann La Roche Dérivés d'aminopyrimidine au titre de modulateurs de lrrk2
BR112014009531A8 (pt) 2011-10-20 2018-01-16 Glaxosmithkline Llc aza-heterociclos bicíclicos substituídos e análogos como moduladores de sirtuína
RU2014120180A (ru) * 2011-10-20 2015-11-27 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Замещенные бициклические аза-гетероциклы и аналоги в качестве модуляторов сиртуина
MX2015011898A (es) * 2013-03-13 2016-05-05 Genentech Inc Compuestos de pirazolo y usos de los mismos.
CN103626776B (zh) * 2013-12-05 2017-02-15 北京师范大学 吡唑并[1,5‑a]嘧啶氮芥衍生物及其制备方法和肿瘤治疗应用
EP3778605A3 (en) * 2015-02-13 2021-03-10 Dana Farber Cancer Institute, Inc. Lrrk2 inhibitors and methods of making and using the same
MA54092A (fr) 2018-10-30 2021-09-08 Kronos Bio Inc Composés, compositions et procédés de modulation de l'activité de cdk9
EP3886988A1 (en) 2018-11-30 2021-10-06 Merck Sharp & Dohme Corp. 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
CN112921405B (zh) * 2019-12-05 2023-06-27 成都先导药物开发股份有限公司 一种合成On-DNA吡唑并[1，5-a]嘧啶化合物的方法
TW202245774A (zh) * 2021-02-05 2022-12-01 大陸商上海齊魯製藥研究中心有限公司 嘧啶或吡啶並雜環類腺苷受體抑制劑及其製備方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2057089A1 (en) * 1990-12-07 1992-06-08 Eric E. Allen Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
AU743910B2 (en) 1997-03-24 2002-02-07 Kyowa Hakko Kirin Co., Ltd. {1,2,4}triazolo{1,5-c}pyrimidine derivatives
US6355653B1 (en) * 1999-09-06 2002-03-12 Hoffmann-La Roche Inc. Amino-triazolopyridine derivatives
DE60032249T2 (de) * 1999-09-30 2007-07-19 Neurogen Corp., Branford Amino-substituierte Pyrazolo-[1,5-a]-1,5-Pyrimidine und Pyrazolo-[1,5-a]-1,3,5-Triazine
MY137843A (en) 2002-09-04 2009-03-31 Schering Corp Pyrazolopyrimidines as cyclin dependent kinase inhibitors
MXPA05008955A (es) * 2003-02-28 2006-02-22 Teijin Pharma Ltd Derivados de pirazolo [1,5-a] pirimidina.
US20070179161A1 (en) * 2003-03-31 2007-08-02 Vernalis (Cambridge) Limited. Pyrazolopyrimidine compounds and their use in medicine
US20080070932A1 (en) 2003-04-09 2008-03-20 Chi Vu Triazolo[ 1,5-A] Pyrimidines And Pyrazolo[ 1,5-A] Pyrimidines And Methods Of Making And Using The Same

Also Published As

Publication number Publication date
HK1108882A1 (en) 2008-05-23
US7741318B2 (en) 2010-06-22
ES2327145T3 (es) 2009-10-26
WO2006068954A3 (en) 2006-12-07
CN101119998A (zh) 2008-02-06
EP1836205B1 (en) 2009-06-10
EP1836205A2 (en) 2007-09-26
US20060135526A1 (en) 2006-06-22
CA2591125A1 (en) 2006-06-29
ATE433454T1 (de) 2009-06-15
DE602005014891D1 (de) 2009-07-23
WO2006068954A2 (en) 2006-06-29
JP2008524330A (ja) 2008-07-10

Similar Documents

Publication Publication Date Title
MX2007007604A (es) Antagonistas del receptor de pirazolo[1,5-a]pirimidina adenosina a2a.
MX2007004250A (es) Derivados de imidazo[1,5-a]triazolo[1,5-d]benzodiazepina para el tratamiento de trastornos cognitivos.
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
NO20055510L (no) 2-alkynyl- og 2-alkenylpyrazolo [4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidin-adenosin A2A-reseptorantagonister
WO2006084017A3 (en) Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
GEP20084367B (en) Diazepinoindole derivatives as kinase inhibitors
DE60326646D1 (de) Benzisoxazolderivate, die sich als inhibitoren von proteinkinasen eigen
GEP20063958B (en) 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
PE20060185A1 (es) ANTAGONISTA DEL RECEPTOR A2A DE LA ADENOSINA CON ESTRUCTURA DE PIRAZOLO--[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PIRIMIDINA
YU41299A (sh) Atropizomeri 3-aril-4(3h)-hinazolinona i njihova upotreba kao ampa-receptor antagonista
MXPA04000886A (es) Derivados de triazolil-imidazopiridina y triazolilpurinas empledos como ligandos del receptor de adenosina a2a y su uso como medicamentos.
MXPA03010961A (es) Compuestos de tiazol utiles como inhibidores de proteinas cinasas.
TR200000197T2 (tr) Yeni bileşimler
MXPA03007140A (es) Derivados de carbolina.
MX2007006497A (es) Nuevos derivados de pirrolo [3,2-d] pirimidin-4-ona y su uso en terapia.
MX337817B (es) Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
NO20054085L (no) Substituerte heksahydropyrazino [1,2-a]pyrimidin-4,7-dionderivater, fremgangsmater for fremstilling og anvendelse derav som medikamenter
NZ517758A (en) Pyrazolopyrimidines useful as therapeutic agents
TW200503705A (en) 3-amino chroman and 2-amino tetralin derivatives
MXPA04005847A (es) Compuestos derivados de 4-sulfuro/sulfoxido/sulfonil-1h-pirazolilo, para uso en enfermedades asociadas con el receptor 5-ht2c.
ATE407935T1 (de) Thieno(3,2-d)pyrimidine und furano(3,2- d)pyrimidine und deren verwendung als antagonisten an purinergen rezeptoren
NZ512981A (en) Use of pyridazino[4,5-b]indole-1-acetamide derivatives for treating diseases related to the dysfunction of peripheral benzodiazepine receptors
ATE389653T1 (de) 4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen
WO2004043362A3 (en) Acyl guanidine compounds and use thereof
ES2324794T3 (es) Imidazo(4,5-c)pyridine componente y metodo de tratamiento antiviral.

Legal Events

Date Code Title Description
FG Grant or registration